Gjør som tusenvis av andre bokelskere
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.Du kan når som helst melde deg av våre nyhetsbrev.
Do corporations own the genetic codes to our future? McGiffen explores who's in control and what it means.
The political dynamics of the European Union can often appear confusing, shrouded as they are in complex legislative processes. This book offers a clear and thorough critical introduction to the origins, development and current direction of the EU, and pinpoints the major policy debates animating decision-makers.*BR**BR*This revised and updated edition offers a well-illustrated analysis of each of the EU's major policy areas, and covers arguments both for and against the EU. McGiffen explores subjects including enlargement, internal and external security, the Euro, trade, the environment, employment, transport and regional policy. He explains how and why the debate about membership is frequently and falsely presented as if it were a conflict between 'nationalism' and 'internationalism', and argues instead that the EU is merely one of a number of possible solutions to the the economic and political problems facing Europe.*BR**BR*Published in association with Spectre.
Frankenfoods, designer babies, Dolly the Sheep and Raelian fantasists: few subjects generate as much controversy and misinformation as biotechnology. This book takes the reader behind the headlines to examine the new laws on genetic-based technologies, who's making them, and why. *BR**BR*Steven P. McGiffen offers a lucid analysis of the real implications of biotechnology legislation in the US and the EU, and contrasts it with approaches to agricultural and medical biotech in the rest of the world. He argues that the EU and America are removing decision-making power from the people and their elected representatives. Biotechnology regulation is a local manifestation of a global process of transferring power: from the people to corporations, from poor countries to rich ones, from the public to the private.*BR**BR*He shows that biotechnology demands effective and democratic international decision-making procedures - and that we are very far from achieving them. This is an indispensable guide for activists and anyone who wants to know more about how to control biotech regulation and how to resist handing control of our future to corporations.
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.